Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 7/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3083718 | 0.89 | HPGD (0.63) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL13444627 | 0.86 | LMNA (0.61) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL7101006 | 0.86 | MAPT (0.60) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL12652047 | 0.86 | HPGD (0.59) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL12124929 | 0.85 | RAB9A (0.69) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL6373144 | 0.84 | MAPT (0.59) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL4286423 | 0.84 | HPGD (0.58) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL7338663 | 0.84 | TSHR (0.65) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL87450 | 0.84 | CA1 (0.83) | HPGDRECQLCA1CA2CA12 | |
| SCHEMBL3233695 | 0.83 | HPGD (0.65) | HPGDRECQLCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925241-A | Preservative for cosmetics and preparation process thereof | 利洁士医疗器械(重庆)有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-11872212-B2 | Self-healing organic crystals | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IISER) KOLKATA (IN) | 2024-01-16 | — | — | US | claimed |
| JP-3095147-A | — | — | None | — | — | JP | disclosed |
| US-12612395-B2 | Rocaglate derivatives and uses thereof | TRUSTEES OF BOSTON UNIVERSITY (US) | 2026-04-28 | — | — | US | disclosed |
| EP-4684019-A2 | DENDRITIC CONJUGATES FOR THE BRAIN DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES | University of Massachusetts (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-3708167-B1 | IMMUNOMODULATING TREATMENTS OF BODY CAVITIES | UROGEN PHARMA LTD (IL) | 2026-01-28 | — | — | EP | disclosed |
| US-12508271-B2 | Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer imaging or radiotherapy | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| CN-111670199-B | Monoclonal antibody NEO-201 for treating human carcinoma | 精密生物制品股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| EP-2877854-B2 | FGFR-TACC FUSION PROTEINS AND METHODS THEREOF | UNIV COLUMBIA (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-119979609-A | Plant source compound target identification method acting on insect 5-hydroxytryptamine receptor | 浙江大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-119925241-A | Preservative for cosmetics and preparation process thereof | 利洁士医疗器械(重庆)有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20230105186-A1 | Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases | JOHNS HOPKINS UNIVERSITY | 2023-04-06 | — | — | US | disclosed |
| US-20230051178-A1 | Self-Healing Organic Crystals | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IISER) KOLKATA (IN) | 2023-02-16 | — | — | US | disclosed |
| US-11547729-B2 | Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-01-10 | — | — | US | disclosed |
| CN-115335030-A | Pigment comprising radish extract and montmorillonite | 奇华顿股份有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-115305241-A | Method for quickly and effectively obtaining high-purity glioma stem cell culture | 韩欣欣 | 2022-11-08 | — | — | CN | disclosed |
| EP-2877854-B1 | FGFR-TACC FUSION PROTEINS AND METHODS THEREOF | UNIV COLUMBIA (US) | 2022-09-07 | — | — | EP | disclosed |
| US-11414468-B2 | Factor B and C2 protein point mutants, a method for enhancing the activity of anti-cancer antibodies, the pharmaceutical composition and the use of mutants | GDANSKI UNIWERSYTET MEDYCZNY (PL) | 2022-08-16 | — | — | US | disclosed |
| US-11407991-B2 | Nucleic acid extraction from heterogeneous biological materials | EXOSOME DIAGNOSTICS, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| JP-H0395147-A | MOLECULAR CRYSTAL | MIYATA SEIZO | 1991-04-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11872212-B2 | Self-healing organic crystals | DNAJA1, DNAJA3, LIG4 | HPGD 3639/4885RECQL 376/4885CA1 2997/4885 |
| US-12612395-B2 | Rocaglate derivatives and uses thereof | GLRB, SRR, HCAR3 | HPGD 1791/4885RECQL 3160/4885CA1 1149/4885 |
| US-20230051178-A1 | Self-Healing Organic Crystals | DNAJA1, DNAJA3, LIG4 | HPGD 3639/4885RECQL 376/4885CA1 2997/4885 |
| US-12508271-B2 | Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer imaging or radiotherapy | KLK3, CTSA, PTMA | HPGD 2692/4885RECQL 3883/4885CA1 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.